您的位置:PharmaNews 行业信息 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

WILEX AG recommends shareholders not to accept the mandatory offer of dievini Hopp BioTech holding GmbH & Co. KG(2)
本文章共2524字,分2页,当前第2页,快速翻页:

 

Kind Regards,

WILEX AG

Katja Arnold (CIRO)

Senior Manager Corporate Communications

Grillparzerstr. 10

81675 Munich, Germany

Tel.: +49 (0)89-41 31 38-126

Fax: +49 (0)89-41 31 38-99

Email: investors@wilex.com

 

WILEX AG | Grillparzerstraße 10, 81675 München, Deutschland, Tel. +49 (0) 89 413138-0, Fax +49 (0) 89 413138-99, info@wilex.com, www.wilex.com | Vorstand: Prof. Dr. Olaf G. Wilhelm (Vorsitzender), Dr. Paul Bevan, Peter Llewellyn-Davies | Dr. Thomas Borcholte | Vorsitzender des Aufsichtsrates: Dr. Georg F. Baur | Sitz der Aktiengesellschaft: München, Amtsgericht München, HRB 136670 | HypoVereinsbank München, BLZ 700 202 70, Kto. 5800225304 | Deutsche Bank München, BLZ 700 700 10, Kto. 1616150

In case you do not wish to receive information from WILEX any more, we kindly ask you to inform us accordingly via e-mail (press@wilex.com). We will then remove your name from our distribution list.
 

转载自pharmaLive


 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

  VaxGen and diaDexus Complete Merger

  WuXi PharmaTech Well Positioned to Conti

Devax Receives CE Mark for the AXXESS Dr

Employment at NJ Biotechnology Companies

Federal Jury Finds Cornell University's

Conatus Pharmaceuticals Acquires Pfizer'

Charles River Announces Mutual Terminati

USIBC Salutes Abbott Laboratories for 10

药明康德出售搁浅 作价过高或成祸首

全球制药业R&D投入更趋理性

黑龙江研制中药壳聚糖复合药膜 可加速顽固性

重磅!抗生素政策再度收紧,集采下所剩不多

相关评论

    
本文章所属分类:首页 行业信息